Fichero a descargar de la publicación mostrada - Sociedad ...

Octubre 2011 INFECCIONES RELACIONADAS CON CATÉTERES VASCULARES Pág. 54______________________________________________________________________________225. Mayhall CG. Diagnosis and management of infections of implantable devices used for prolonged venousaccess. Curr Clin Top Infect Dis 1992; 12:83-110.226. Beathard GA, Urbanes A. Infection associated with tunneled hemodialysis catheters. Semin Dial 2008;21:528-38.227. Ingram J, Weitzman S, Greenberg ML, Parkin P, Filler R. Complications of indwelling venous access lines inthe pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports.Am J Pediatr Hematol Oncol 1991; 13:130-6.228. El-Ahdab F, Benjamin DK Jr., Wang A, et al. Risk of endocarditis among patients with prosthetic valves andStaphylococcus aureus bacteremia. Am J Med 2005; 118:225-9.229. Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanentpacemakers or implantable cardioverter-defibrillators. Circulation 2001; 104:1029-33.230. Biffi R, de BF, Orsi F, et al. Totally implantable central venous access ports for long-term chemotherapy. Aprospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. AnnOncol 1998; 9:767-73.231. Yildizeli B, Lacin T, Batirel HF, Yuksel M. Complications and management of long-term central venousaccess catheters and ports. J Vasc Access 2004; 5:174-8.232. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia andoutcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997; 127:275-80.233. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999;34:1114-24.234. Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO. Tunnelled haemodialysiscatheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. NephrolDial Transplant 2006; 21:1024-31.235. Ashby DR, Power A, Singh S, et al. Bacteremia associated with tunneled hemodialysis catheters: outcomeafter attempted salvage. Clin J Am Soc Nephrol 2009; 4:1601-5.236. Hanna H, Afif C, Alakech B, et al. Central venous catheter-related bacteremia due to gram-negative bacilli:significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol 2004; 25:646-9.237. Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y. Management of the catheter in documentedcatheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis 2009; 49:1187-94.238. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. ClinMicrobiol Rev 2002; 15:167-93.239. von EC, Jansen B, Kohnen W, Becker K. Infections associated with medical devices: pathogenesis,management and prophylaxis. Drugs 2005; 65:179-214.240. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technologyfor rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37:1771-6.241. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int JAntimicrob Agents 2010; 35:322-32.242. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candidabiofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob AgentsChemother 2002; 46:1773-80.